Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Current Leases (2023 - 2025)

Historic Current Leases for CG Oncology (CGON) over the last 3 years, with Q3 2025 value amounting to $912000.0.

  • CG Oncology's Current Leases rose 30533.33% to $912000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $912000.0, marking a year-over-year increase of 30533.33%. This contributed to the annual value of $186000.0 for FY2024, which is 1428.57% down from last year.
  • Per CG Oncology's latest filing, its Current Leases stood at $912000.0 for Q3 2025, which was up 30533.33% from $288000.0 recorded in Q2 2025.
  • In the past 5 years, CG Oncology's Current Leases registered a high of $912000.0 during Q3 2025, and its lowest value of $186000.0 during Q4 2024.
  • Over the past 3 years, CG Oncology's median Current Leases value was $231000.0 (recorded in 2024), while the average stood at $317500.0.
  • Its Current Leases has fluctuated over the past 5 years, first crashed by 1428.57% in 2024, then surged by 30533.33% in 2025.
  • Over the past 3 years, CG Oncology's Current Leases (Quarter) stood at $217000.0 in 2023, then decreased by 14.29% to $186000.0 in 2024, then skyrocketed by 390.32% to $912000.0 in 2025.
  • Its Current Leases was $912000.0 in Q3 2025, compared to $288000.0 in Q2 2025 and $255000.0 in Q1 2025.